[Summary] It is an innovation-driven pharmaceutical group integrating drug resea
Nanjing Zhengke Pharmaceutical Co., Ltd. (securities abbreviation: Zhengke Pharmaceutical, stock code: 836342) was founded in 2001. The company is located by the Yangtze River in the beautiful ancient capital of six dynasties and in the * Development Zone - Nanjing Economic and Technological Development Zone, and owns two wholly-owned subsidiaries: Guangdong Yongzheng Pharmaceutical Co., Ltd. and Nanjing Hengzheng Pharmaceutical Research Institute Co., Ltd. The company is an innovation-driven pharmaceutical group integrating drug R&D, manufacturing, and product sales, and is a high-tech enterprise. It has successively obtained qualifications and titles such as "2021 Jiangsu Province Specialized, Refined, Distinctive and Innovative Little Giant Enterprise", "Jiangsu Province Enterprise Technology Center", "Jiangsu Province Neuro-Psychiatric System Drug Engineering Technology Research Center", "Jiangsu Province Private Science and Technology Enterprise", "2017 Jiangsu Province Top 100 Most Growing High-Tech Enterprises", "Nanjing Postdoctoral Innovation Practice Base", "Nanjing Intellectual Property Demonstration Enterprise", "Nanjing Enterprise Technology Center", "Nanjing Neuro-Psychiatric System Drug Engineering Technology Research Center", and "Nanjing Engineering Technology Research Center".
With the corporate vision of "Accompanying Health, Benefiting All Living Beings" and the corporate mission of "Leading the Pharmaceutical Industry, Building a Happy Home", the company provides safe and effective assured medicines to the whole society. Zhengke Pharmaceutical's products involve many dosage forms, including oral solid preparations, oral liquid preparations, small-volume injections, and powder injections. In fields such as cardiovascular and cerebrovascular drugs, neuro-psychiatric system drugs, urinary system drugs, and anesthesia and adjuvant drugs, it has many highly market-recognized and competitive products.
For more than ten years, the company has taken new drug innovation as the strategic basis for development, continuously improved its new drug innovation level, and gathered a large number of outstanding scientific research talents. The company has 17 invention patents with independent intellectual property rights. Among the pharmaceutical listed enterprises on the New Third Board, Zhengke Pharmaceutical ranks * in R&D strength (according to the statistics of the number of varieties under research of New Third Board pharmaceutical listed enterprises in the 2017 insight database). It has also successively won the titles of "2015 China's Top 20 Innovative Pharmaceutical Enterprises"; "2018 China Pharmaceutical Industry Most Investment-Valuable Enterprise (Non-Listed)"; and "2023 China Pharmaceutical Industry Most Investment-Valuable Enterprise". The above honorary titles have been professionally assessed, relying on data sources such as the new drug R&D monitoring database, comprehensive drug database, hospital market analysis system, and China pharmaceutical retail database, and are selected by examining from two levels: the dimensions of drug innovation, strategy, maturity, development, and competition, and the dimensions of enterprise characteristics, leadership, scale, stability, and growth, comprehensively considering enterprise scale, R&D strength, product layout, future development potential, etc. These honors fully reflect the company's comprehensive strength and competitiveness.
Zhengke Pharmaceutical's sales network covers provinces, cities, and counties across the country, and it has a high-quality sales team full of passion and vitality. The company adheres to customer-centeredness and has won the trust and praise of customers and patients with high-quality products and first-class services. The company's dexketoprofen trometamol injection is an exclusive new drug in national negotiations, a new-generation safe and potent non-steroidal anti-inflammatory analgesic, and a blockbuster product in a hundred-billion market.
Zhengke Pharmaceutical has always adhered to the values of "Integrity, Innovation, Focus, and Win-Win", upheld the corporate business philosophy of "People-Oriented, Integrity First, Science-Oriented, and Beginning with the End", worked hard and forged ahead, been brave in innovation, made every effort to build the "Zhengke" brand, continuously surpassed itself, and written new chapters for revitalizing the national pharmaceutical industry and for the health of all mankind.
What does Nanjing Zhengke Pharmaceutical Co., Ltd. require? Who is Zhengke Pharmaceutical hiring? Zhengke Pharmaceutical recruitment: 销售类占比最多占60.8%,其次是经营管理类占59.2%. What education can get in at Zhengke Pharmaceutical? 本科占比最多占49.6%,其次是大专占40.8%. High education required at Zhengke Pharmaceutical? 硕士占4.4%,博士占2.8%. Work experience required at Zhengke Pharmaceutical? 3-5年占比最多占38.4%,其次是不限占25.6%. Where are the job locations at Zhengke Pharmaceutical? 南京占比最多占31.6%,其次是广州占9.2%. Based on job postings from the past year, for reference only.
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows